Skip to main content
minnie sarwal
Faculty

Minnie Sarwal, MD, PhD

Professor, Surgery

Minnie Sarwal is a Professor in Residence, Surgery, Division of Multi-Organ Transplantation; Co-Director of the Kidney and Pancreas Transplant Program at the University of California San Francisco (UCSF);  Director of the Precision Transplant Medicine Lab at UCSF, Co-Director of the T32 Training Program in Transplant Surgery, and holds courtesy appointments in Medicine and Pediatrics at UCSF. She is on Faculty for the Masters in Translational Medicine Program (Berkeley/UCSF). She was an elected Senior Treasurer and Councilor for the Transplantation Society and the International Pediatric Transplant Association (IPTA). She has previously held positions of Medical Director, Pediatric Kidney Transplant Program and Professor of Pediatrics, Immunology and Surgery at Stanford University for 16 yrs and has held numerous leadership roles at many transplant societies (AST, ASTS, IPTA, FOCIS, TTS, IPNA, ESOT). She holds an MD from India, post-graduate training at Guy’s Hospital, London, UK, and a PhD in Molecular Genetics from Cambridge University (Christ’s College), mentored by Nobel Laureate Sydney Brenner. She obtained her Diploma in Child Health (London University, UK) and Membership to the Royal College of Physicians (MRCP, London) and is elected Fellow of the Royal College of Physicians, London and a member of the Royal Society of Medicine.

Dr. Sarwal serves as a reviewer and chair on NIH study sections and the Department of Defense and advises the FDA Commissioner as a standing member of the FDA Science Board. Dr. Sarwal is Chief Editor for Frontiers in Medicine (Nephrology; Nature publishing) and has held Associate Editor roles for the American Journal of Transplantation, Clinical Transplantation and Pediatric Transplantation

Research Overview:

Dr. Sarwal is a consecutively funded NIH investigator for over 2 decades with research focused on personalizing transplant immunosuppression and kidney disease management through translational research using high throughput technologies and bioinformatics. She has been Principal Investigator on NIH clinical trials in transplantation and developed the first steroid-free immunosuppression protocol for children undergoing renal transplantation; now adopted worldwide. Minnie has presented and chaired numerous invited scientific seminars and visiting professorship. Her career is marked as a prolific speaker at numerous invited professorships and lectures, and by over 300 peer reviewed publications and awards and distinctions, including the Order of Excellence in Scientific Research (Cambridge, UK, 2002), the Dean’s Graduate Teaching Award (Stanford University, 2005), Junior Faculty Award (CCIS, Stanford University, 2003-6), Key Opinion Leader in Organ Transplantation (TTS; 2007-2009), Senator at Large (Stanford Faculty Senate), TTS-Roche Award for Outstanding Achievement Transplantation Science (Clinical, 2010), and the Cuneo Richardson Award for Scientific Excellence (National Kidney Foundation, 2012). Minnie has actively mentored more than 150 students, post-docs and junior faculty and is a prolific teacher and speaker. Minnie holds numerous issued and pending patents and has founded two companies from Stanford University (Organ-I) and UCSF (KitBio), both addressing unmet needs for improved diagnostics for patients with kidney transplants and kidney disease. In her free time, she is a classical pianist, and enjoys hiking, tennis, good food and friends.

Computational health science interests: